机译:聚乙二醇化干扰素α-2b在年轻的1型神经纤维瘤病和无法切除的丛状神经纤维瘤患者中进行的II期临床试验
Childrens Hosp Pittsburgh, 4401 Penn Ave Pittsburgh, Penn Ave Pittsburgh, PA 4401 USA|AstraZeneca One Medimmune Way, Gaithersburg, MD USA;
Natl Canc Inst, Biostatist & Data Management Sect SS, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA;
Ann & Robert Lurie Childrens Hosp, 225 Chicago Ave, Chicago, IL 60611 USA;
Dana Farber Boston Childrens Canc & Blood Disorde, 450 Brookline Ave, Boston, MA 02215 USA;
AstraZeneca One Medimmune Way, Gaithersburg, MD USA;
AstraZeneca One Medimmune Way, Gaithersburg, MD USA;
Childrens Hosp Pittsburgh, 4401 Penn Ave Pittsburgh, Penn Ave Pittsburgh, PA 4401 USA;
Natl Canc Inst, Biostatist & Data Management Sect SS, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA;
AstraZeneca One Medimmune Way, Gaithersburg, MD USA;
Dana Farber Boston Childrens Canc & Blood Disorde, 450 Brookline Ave, Boston, MA 02215 USA|Childrens Hosp Chicago, Ann & Robert H Lurie, 225 E Chicago Ave.,Box 30, Chicago, IL USA;
Dana Farber Boston Childrens Canc & Blood Disorde, 450 Brookline Ave, Boston, MA 02215 USA;
Natl Canc Inst, Biostatist & Data Management Sect SS, Pediat Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA;
clinical trials; interferon; neurofibromatosis type 1; plexiform neurofibromas; pediatrics;
机译:吡非尼酮在患有1型神经纤维瘤病和进行性丛状神经纤维瘤的儿童和青少年中的II期试验
机译:西罗莫司治疗1型进行性神经纤维瘤病相关的丛状神经纤维瘤:神经纤维瘤病临床试验联盟II期研究
机译:法尼基转移酶抑制剂替非法尼在患有1型神经纤维瘤和进行性丛状神经纤维瘤的儿童和青少年中的2期随机,灵活,交叉,双盲,安慰剂对照试验
机译:使用QTRAP 6500定量在人血清中的聚乙二醇化药物缀合物干扰素Alfa-2b
机译:涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募,保留和依从性报告。
机译:聚乙二醇化干扰素α-2b在年轻的1型神经纤维瘤病和无法切除的丛状神经纤维瘤患者中进行的II期临床试验
机译:聚乙二醇干扰素-α-2b在年轻的丛状神经纤维瘤患者中的I期试验
机译:塞来昔布用于控制神经纤维瘤病中症状性丛状神经纤维瘤的前瞻性随机临床试验1